Ilyang Pharmaceutical Co.,Ltd Asset Resilience Ratio

Latest as of June 2026: 1.08%

Ilyang Pharmaceutical Co.,Ltd asset resilience ratio. Ilyang Pharmaceutical Co.,Ltd (007575) has an Asset Resilience Ratio of 1.08% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Ilyang Pharmaceutical Co.,Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩4.87 Billion

≈ $3.30 Million USD Cash + Short-term Investments

Total Assets

₩451.72 Billion

≈ $306.13 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Ilyang Pharmaceutical Co.,Ltd (2014–2025)

Asset resilience ratio of Ilyang Pharmaceutical Co.,Ltd from 2014 to 2025. This chart shows how Ilyang Pharmaceutical Co.,Ltd's Asset Resilience Ratio has changed over time. Read 007575 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Ilyang Pharmaceutical Co.,Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 007575 total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩4.87 Billion	1.08%
Total Liquid Assets	₩4.87 Billion	1.08%

Asset Resilience Insights

Limited Liquidity: Ilyang Pharmaceutical Co.,Ltd maintains only 1.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Ilyang Pharmaceutical Co.,Ltd Industry Peers by Asset Resilience Ratio

Compare Ilyang Pharmaceutical Co.,Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Ilyang Pharmaceutical Co.,Ltd Asset Resilience Ratio by Year (2014–2025)

Ilyang Pharmaceutical Co.,Ltd asset resilience ratio by year from 2014 to 2025. The table below shows the annual Asset Resilience Ratio data for Ilyang Pharmaceutical Co.,Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.31%	₩5.97 Billion ≈ $4.05 Million	₩457.33 Billion ≈ $309.93 Million	-0.66pp
2024-12-31	1.97%	₩8.49 Billion ≈ $5.76 Million	₩431.03 Billion ≈ $292.10 Million	+0.07pp
2023-12-31	1.90%	₩6.78 Billion ≈ $4.59 Million	₩356.66 Billion ≈ $241.70 Million	+0.81pp
2022-12-31	1.09%	₩5.42 Billion ≈ $3.67 Million	₩498.19 Billion ≈ $337.61 Million	-5.86pp
2021-12-31	6.95%	₩34.34 Billion ≈ $23.27 Million	₩494.27 Billion ≈ $334.96 Million	+6.89pp
2020-12-31	0.06%	₩270.87 Million ≈ $183.56K	₩439.12 Billion ≈ $297.58 Million	+0.05pp
2019-12-31	0.01%	₩43.52 Million ≈ $29.49K	₩437.46 Billion ≈ $296.46 Million	-1.25pp
2018-12-31	1.26%	₩5.46 Billion ≈ $3.70 Million	₩432.25 Billion ≈ $292.93 Million	+0.51pp
2017-12-31	0.76%	₩3.31 Billion ≈ $2.24 Million	₩436.37 Billion ≈ $295.72 Million	+0.75pp
2016-12-31	0.01%	₩43.85 Million ≈ $29.72K	₩431.26 Billion ≈ $292.26 Million	-0.07pp
2015-12-31	0.08%	₩354.85 Million ≈ $240.48K	₩431.63 Billion ≈ $292.51 Million	-0.05pp
2014-12-31	0.13%	₩581.48 Million ≈ $394.06K	₩430.83 Billion ≈ $291.97 Million	--

pp = percentage points

About Ilyang Pharmaceutical Co.,Ltd

KO:007575 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$83.96 Million

₩123.89 Billion KRW

Market Cap Rank

#19654 Global

#998 in Korea

Share Price

₩6820.00

Change (1 day)

-0.15%

52-Week Range

₩6820.00 - ₩8380.00

All Time High

₩141909.13